An Activatable Phototheranostic Probe for Anti‐hypoxic Type I Photodynamic‐ and Immuno‐Therapy of Cancer

Abstract

Photodynamic therapy (PDT), which utilizes type I photoreactions, has great potential as an effective cancer treatment because of its hypoxia‐tolerant superiority over the commonly used type II pathway. A few type I photosensitizers have been exploited; however, they majorly induce cytotoxicity and possess poor tumor specificity and low‐efficient theranostics. To resolve this issue, we herein report an aminopeptidase N (APN)‐activated type I phototheranostic probe (CyA) for anti‐hypoxic PDT in conjunction with immunotherapy for effective cancer treatment. CyA can specifically activate near‐infrared fluorescence, photoacoustic signals, and phototoxicity following APN‐induced substrate cleavage and the subsequent generation of active phototheranostic molecules (such as CyBr). CyA endows specific imaging capabilities and effective phototoxicity towards tumor cells overexpressing APN under both normoxia and hypoxia. In addition, the locally activatable PDT induces systemic antitumor immune responses. More importantly, the integration of localized activated PDT and systemic immunotherapy evokes enhanced therapeutic effects with improved tumor inhibition efficiency in live mice compared with individual treatments. This study aims to present an activatable phototheranostic probe for effective hypoxia‐tolerant PDT and combination therapy.This article is protected by copyright. All rights reserved

Magnetic Bimetallic Heterointerface Nanomissiles with Enhanced Microwave Absorption for Microwave Thermal/Dynamics Therapy of Breast Cancer

“…Moreover, oxygen consumption will further exacerbate the hypoxia TME during MDT, thereby promoting tumor proliferation and metastasis and ultimately leading to tumor recurrence. Therefore, the catalytic generation of O 2 will help to improve MWT and promote MDT (Figure k,l). − The O 2 content of the mixed solution was first quantified using a dissolved oxygen meter to evaluate the O 2 production catalyzed by MN and MNR under MW irradiation, in which the O 2 level was essentially unchanged with the addition of H 2 O 2 to H 2 O at 25 °C, but a significant increase was detected upon subsequent addition of MN and MNR with the O 2 concentrations of 8.48 mg/L and 28 mg/L, respectively, verifying that Ru 4+ in MNR could enhance the catalytic decomposition of H 2 O 2 to produce O 2 . Thus, the MAMs of MNR could effectively deplete GSH and generate O 2 , alleviating hypoxia, disrupting the redox balance in tumor cells, and finally improving the MTDT to boost the therapeutic efficacy.…”

Tumor Microenvironment Activatable Nanoprodrug System for In Situ Fluorescence Imaging and Therapy of Liver Cancer

“…In comparison with other imaging analytical methods, near-infrared (NIR) fluorescence imaging is widely applied in the study of biosystems because of its distinct merits such as low cost, high sensitivity, and noninvasive. − Especially, small molecule probes based on organic dyes, with lower toxicity and easy metabolism, have become robust tools for the observation of various bioanalytes. − Up to now, diverse small molecule fluorescent probes have been prepared to detect pH, ROS, enzymes, etc. in tumor cells. − Nevertheless, the majority of reported probes were at risk of diffusion owing to the lack of in situ labeling capability, leading to spurious signals, and were not appropriate for tracking in the long term. Moreover, they could also result in signal deficiencies in bioimaging, thus giving unreliable measurements.…”